Ribosomal fractions were obtained from a culture of type 2 Neisseria gonorrhoeae strain P-17 which was isolated from a patient with an acute gonococcal infection; these fractions were purified to eliminate the components of the outer membrane complex by affinity chromatography (Sepharose-anti-outer membrane complex antibody conjugates were used as the solid immunosorbent), and the resulting preparation was designated the purified ribosomal fraction. The purified ribosomal fraction was used to detect antibody activity in sera obtained from culture-positive asymptomatic carriers and healthy controls by a passive hemagglutination test. This passive hemagglutination test had a specificity of 100% for both sexes and sensitivities of 99.4 and 88.2% for female and male carriers, respectively, when an antibody titer of more than 1:3 was defined as abnormal.
Ribosomal fractions were obtained from a culture of type 2 Neisseria gonorrhoeae strain P-17 which was isolated from a patient with an acute gonococcal infection; these fractions were purified to eliminate the components of the outer membrane complex by affinity chromatography (Sepharose-anti-outer membrane complex antibody conjugates were used as the solid immunosorbent), and the resulting preparation was designated the purified ribosomal fraction. The purified ribosomal fraction was used to detect antibody activity in sera obtained from culture-positive asymptomatic carriers and healthy controls by a passive hemagglutination test. This passive hemagglutination test had a specificity of 100% for both sexes and sensitivities of 99.4 and 88.2% for female and male carriers, respectively, when an antibody titer of more than 1:3 was defined as abnormal. Absorption of the sera with nongonococcal organisms did not affect the antibody activity, and no significant difference in antigenicity among various N. gonorrhoeae strains was observed in ribosomal fractions. An enzyme-linked immunosorbent assay was also used to measure the relative amounts of specific antibodies to the purified ribosomal fraction, and this assay revealed that the anti-purified ribosomal fraction antibodies were immunoglobulin G.
During the past 10 years, there has been increasing interest in serological methods for the diagnosis of gonococcal infections. A variety of serological techniques have been described, including the complement fixation test (4, 26) , flocculation (18, 31) , direct hemagglutination (9, 19, 32) , and the indirect immunofluorescence test (2, 34, 35) . Recently, a radioimmunoassay (1, 21) and an indirect hemagglutination test (25) in which gonococcal pilus antigen is used to detect gonococcal antibodies have been described, but the results of these tests have been variable because of a lack of sufficient sensitivity or specificity. Except for the tests based on purified pili, the existing serological tests use either whole gonococci or chemically undefined extracts as antigens. All of these tests give some nonspecific results because of cross-reactions with antibodies to other Neisseria species and organisms sharing antigens with the gonococci.
Another problem is that these tests cannot differentiate a current infection from a past infection. However, serological tests might be of some help in performing epidemiological surveys to detect asymptomatic carriers of Neisseria gonorrhoeae. Furthermore, the importance of serological studies is emphasized by recent demonstrations that asymptomatic gonococcal infections are common in men as well as in women (13) and that male asymptomatic carriers are more common than generally supposed (22) .
We have studied the immunological activities of the ribosomal fraction of Salmonella typhimurium and have shown that circulating antibodies to the ribosomal fraction, which could be demonstrated by a passive hemagglutination assay (PHA), exist in the sera of mice immunized with the ribosomal fraction (16) . Therefore, we isolated the ribosomal fraction from N. gonorrhoeae and used it for PHA antigen. In this paper the preliminary findings of an investigation into the use of this ribosomal fraction in a PHA to detect antibodies to microsomal fractions of N. gonorrhoeae in asymptomatic gonococcal patients are reported. In addition, the enzyme-linked immunosorbent assay (ELISA) was used to measure the relative amounts of specific antibodies against the ribosomal fraction.
MATERIALS AND METHODS Population. Sera were obtained from asymptomatic and symptomatic persons. An asymptomatic carrier was a patient who had no clinical symptoms but had a positive culture. A symptomatic case was a culture-or smear-positive patient with clinical symptoms. Specimens were taken from the cervix of each female patient and from within the urethral canal of each male patient for culture and Gram staining. Some patients were followed up from an earlier attack of gonorrhea. Normal control sera were obtained from healthy students to whom the purpose of the investigation had been explained. Bacteria and culture. N. gonorrhoeae was obtained from fresh patient isolates and was identified by Gram staining, cultural characteristics, oxidase reactivity, and sugar fermentations. Piliated gonococci (strain P-17, isolated in our laboratory) having P+ or P"+ phenotypes were used throughout the preparation of the ribosomal fraction. Bacteria were cultured on solid medium (GC agar base) supplemented with 1% IsoVitaleX. Cultivation of gonococci in 1 liter of liquid medium was accomplished by using a 5-liter fermentation bottle. The medium in the bottle was identical to the solid medium except that starch, 1% (wt/vol) glucose, and 0.1% (wt/vol) sodium bicarbonate were added. The culture was grown at 37°C with continuous revolution after the culture bottle was tightly capped with a rubber stopper.
Preparation of antigens. (i) Crude OMC. Outer membrane complex (OMC) was prepared as described by Zollinger et al. (36) . Briefly, 50 g of wet packed cells suspended in TSE buffer (0.05 M Tris-hydrochloride, 0.15 M NaCI, 0.01 M EDTA, pH 7.4) was incubated at 60°C for 30 min and subjected to mild shearing in an Omnimixer, and then the OMC was separated by centrifugation. The OMC sedimented by centrifugation at 100,000 x g was suspended in water and lyophilized. A portion of this lyophilized OMC was suspended in 2 ml of a 25% (wt/wt) sucrose solution in TSE buffer to a concentration of 2 mg of outer membrane material per ml and was applied to a discontinuous gradient prepared by layering sequentially 2.0-ml portions of sucrose solutions ranging in concentration from 65 to 25% (wt/wt) in nitrocellulose centrifuge tubes. Samples were centrifuged in an RPS 27-2 rotor (Hitachi Koki Co., Ltd.) for 18 h at 280,000 x g to isopycnic conditions. The tube contents were fractionated by puncturing the bottoms of the tubes and collecting drops; the absorption of UV light at 280 nm was measured for the fractions, and a single band was obtained and used as an antigen for immunization.
(li) Antiserum to OMC. Rabbits were immunized with OMC emulsified in Freund incomplete adjuvant. Each rabbit received 0.25 ml of the emulsion in each footpad and 1 ml injected subcutaneously in the nape of the neck. The rabbits were boosted subcutaneously three times every week after immunization. The -yglobulin fraction of the antiserum was prepared by precipitation with Na2SO4, using the method of Kekwick (15 The specific rabbit anti-OMC antibodies were conjugated directly to cyanogen bromide-activated Sepharose 4B (Pharmacia) by the method of Cuatrecasas (3). The coupling was carried out with 5 mg of protein per ml at pH 10 and 4°C for 16 h. Sepharose was activated with 100 mg of CNBr per ml of packed Sepharose 4B.
(iv) Purification of the ribosomal fraction by affinity chromatography. The antigens that cross-reacted with anti-OMC antibodies were removed from the ribosomal fraction by passing this material over a 15-ml column containing conjugated Sepharose 4B. Elution was carried out with 0.1 M Tris-hydrochloride buffer (pH 8.2), and the optical densities of 3-ml fractions were measured at 260 nm. A single peak was obtained, concentrated to 1 ml, and used as the PRF. The PRF was pooled and used as the antigen for the serological study. Anti-PRF antiserum prepared in rabbits did not react with lipopolysaccharide or the OMC preparation in the immunodiffusion test.
PHA. The sera of persons with symptomatic or asymptomatic gonococcal infections were examined for the presence of antibodies against the gonococcal PRF by using a PHA. A modification of the original PHA method of Stavitsky (28) was used. For the PHA, 10 volumes of 1.0%o washed sheep erythrocytes was mixed with 3 volumes of 2.5% glutaraldehyde and 1 volume of the PRF (30 ,ug of protein per ml), and the preparation was incubated for 1 h at room temperature. The sheep erythrocytes were washed in phosphate-buffered saline (PBS) three times and treated with 1 M glycine buffer (pH 7.2) overnight, after which the cells were washed in PBS and suspended to a final concentration of 1% in 1% normal human serum in PBS. The PHA was performed in microtiter plates containing 0.025 ml of PBS plus normal human serum, test serum, and sensitized sheep erythrocytes. Agglutination titers were determined after overnight incubation at 4°C.
ELISA procedure. The ELISA was performed as described by Engvall et al. (6) (7) (8) . Disposable polystyrene tubes (13 by 100 mm; Falcon Plastics, Oxnard, Calif.) containing 1 ml of the PRF in 0.05 M carbonate buffer (pH 9.6) (coating buffer) were incubated for 3 h at 37°C. The optimal working concentration of the PRF for use as the coating antigen was determined by the ELISA reaction, using a positive control serum of known titer. The optimal concentration turned out to be 15 p.g of protein per ml. The PRF was diluted to a concentration of 15 jig of protein per ml of coating buffer.
Excess antigen was removed, and the tubes were washed three times with PBS containing 0.05% Tween 20 and 0.02% sodium azide (PBS-Tween). The test sera were diluted 1:1,000 in PBS-Tween, and 0.5-ml portions were added to the tubes coated with PRF and to uncoated tubes. (20) . The protein contents of the immunoglobulins were determined by measuring the absorbance at 280 nm in a 1-cm cuvette, using a value of 13.8 as the absorbance of a 1% solution of protein. RNA was measured by the orcinol method (5), and hexose was determined by the anthrone reaction described by Roe (27) . The method of Weissbach and Hurwitz (33) as modified by Osborne (24) was used for determinations of 2-keto-3-deoxyoctonate. Calculations were made by using the extinction coefficient given by Osborne (24) . Corrections for interference by sialic acid were made based on the sialic acid content of the sample, as determined by the resorcinol method of Svennerholm (29) . Bovine serum albumin (Sigma), yeast RNA (Sigma), L-(+)-rhamnose (Sigma), and 2-keto-3-deoxyoctoiate (Sigma) were used as standards.
Pieparation of microorganisms for absorption studies. Cultures of Staphylococcus aureus, Escherichia coli, Neisseria meningitidis, and Branhamella catarrhalis were obtained from patients. Cells of S. aureus and )F. coli were grown on brain heart infusion agar (Difco Laboratories, Detroit, Mich.) at 37°C for 24 h. N. meningitidis and B. catarrhalis were inoculated onto chocolate agar, plated, and incubated at 37°C for 24 h. All cells were then washed off the agar and suspended in sterile saline. Each suspension was washed three times, suspended in 20 ml of sterile saline containing 0.5% formalin, heat inactivated in a 65°C water bath for 60 min, and checked for viability by plating on the growth medium. Each suspension was centrifuged at 4,000 rpm for 20 min, and the packed cells were suspended in 20 ml of sterile saline and used for the absorption test. Absorption of the asymptomatic patient sera was done by the method of Gaines and Landy (10) . Briefly, the sera (0.6 ml) were mixed with 0.1 ml of packed cells, incubated at 37°C for 1 h, and then kept at 4°C overnight. After centrifugation at 800 x g for 30 min, the absorbed sera were removed and tested for anti-PRF antibody activity in duplicate.
The titers of antibodies against the PRFs prepared from four different strains of N. gonorrhoeae (P-4 and P-5 isolated in the Philippines, N-1 and N-3 isolated in Japan) and from N. meningitidis and B. catarrhalis were also determined in sera of asymptomatic patients by the method described above.
Statistics. Chi-square analysis was used to determine the statistical significance of individual factors in relation to serological results.
RESULTS
Purification and characterization of antigens. An analysis of fractions obtained by isopycnic centrifugation of OMC by absorbance at 280 nm revealed a single band of turbidity at a gradient density of 1.34 g/cm3 (Fig. 1) . A chemical analysis showed that the OMC preparation consisted of protein and lipopolysaccharide and that the level of RNA contamination was about 1% (Table 1). OMC contamination was removed from the ribosomal fraction by affinity chromatography, and a single peak of an RNA-rich fraction was obtained; this was designated the PRF. As Table 1 shows, the ratio of RNA to protein was 2.14, and lipopolysaccharide contamination may have been minimal, although the actual level of contamination was not clear. The PRF had no antigenic components that reacted with anti-OMC antiserum, as determined by the immunodiffusion test.
Correlation of culture with serology. Table 2 shows the distribution of serological results in N. gonorrhoeae cultures. In our preliminary investigation the antibody levels in serum specimens from the patients with gonococcal infections were less than 1:4, as determined by the PHA. Thus, based on these results, the optimal titer of antibody for discriminating between culture-positive and culture-negative cases was arbitrarily selected as .1:4. In women, titers of more than 1:4 were found in both culture-positive and culture-negative individuals. Table 2 shows none of the factots that influenced the PHA results, such as past history and asymptomatic carrier status.
Influence of past gonorrhea on the serological test. In both sexes, past gonorrheal history significantly influenced the results of serological tests (Table 3 ). In female patients with negative cultures, a past history of gonorrhea was responsible for positive serological tests. Even in culture-positive women, the percentage of positive sera was higher among those individuals who had had gonorrhea previously. Very few men with gonorrhea were examined in this study, but the difference in the percentage of positive sera was remarkable when the patients who had had gonorrhea and the patients without a past history of gonorrhea were compared. Fraction Number Table 4 shows that a past history of gonorrhea significantly influenced the results of a smear diagnosis. The percentage of positive sera was not affected by increasing time since the last episode of gonorrhea, as shown by the PRF PHA (Table 5 ). Absorption of asymptomatic patient sera. The antibody activities in the sera of six individuals with positive cultures (female patients F-1, F-2, and F-3 and male patients M-1, M-2, and M-3) were determined against PRF by the PHA. The antibody titers were determined against ribosomal fractions prepared from four different strains of N. gonorrhoeae, N. meningitidis, and B. catarrhalis. No significant antibody activity against PRFs of nongonococcal organisms was observed with these sera, but high antibody activities to PRFs of different gonococcal strains were detected (Table 7) .
To determine the nonspecific reactivity of anti-PRF antibody activity as measured by the PHA, the sera were also absorbed with each of four nongonococcal organisms. No significant decline in the titer of anti-PRF antibody was observed with these absorbed sera, whereas absorption of patient sera with different strains of N. gonorrhoeae reduced the PHA titers to the level of the PRFs of strain P-17 (Table 8) .
Other antigens, such as lipopolysaccharide and the OMC, did not inhibit the human serological reactions if the PRF was used as the PHA antigen.
DISCUSSION
The reason that ribosomal fractions were chosen as antigens for evaluation in this investigation was that the difference in antigenicity among strains of N. gonorrhoeae was very small. Surface antigens, such as pilus, envelope, and OMC antigens, varied among strains; in addition, it has long been known that many organisms undergo reversible mutations between the piliated and nonpiliated phases (11) . Furthermore, ribosomal fractions reportedly induce delayed-type hypersensitivity in guinea pigs (14, 17) . In this study, ribosomal fractions were further purified by affinity chromatography, designated as PRF, and used as antigens for the PHA and ELISA. Ribosomal preparations contained several antigens detected by immunodiffusion unless they were purified by affinity chromatography; these preparations could react to sera even if a serum sample was collected from a healthy control. The protein content in the PRF was about 30%, but no components of the OMC could be detected by the immunodiffusion test and gel electrophoresis after affinity chromatography.
In this study the sera were collected from asymptomatic carriers, as well as from patients with acute gonococcal infections. It was very difficult to find asymptomatic male carriers and collect reliable information on past gonorrheal history, compared with females. When the results of serological examinations were evaluated, only the culture-positive cases were considered. In males the culture-negative, seropositive individuals represented about 48% of the individuals tested, whereas about 16% of the females tested were culture negative and seropositive. Among the culture-negative seropositive individuals, about 91% of the males and 94% of the females had acute infections. Among the culture-positive seropositive individuals, the percentage of the asymptomatic carriers was about 22% in males and abut 45% in females. In our preliminary investigation, the highest titer at day 7 after the appearance of clinical symptoms of a gonococcal infection was 1:4; after day 7 the antibody activity decreased as clinical symptoms disappeared with treatment. Even in acute cases, the antibody titers were very high if the patient had had gonococcal infections in the past. This study was performed to detect the asymptomatic carriers, and at the early stages of individuals. However, if an antibody titer of more than 1:3 was defined as abnormal, the specificity was 100% for both sexes, and the sensitivity was 99.4% for female carriers and 88.2% for male carriers. The ELISA is a very excellent method for detecting specific antibody, and this test was also used in this study to determine the activity and specificity of anti-PRF antibody in sera. If an antibody level of 20 Ecr units was defined as abnormal, the sensitivity was about 93% and the specificity was more than 90%. A correlation between the PHA and the ELISA was not established in this study, but very few asymptomatic carriers with less than 20 Ecr units had a PHA titer of more than 1:3. The ELISA revealed that the anti-PRF antibody was IgG. Antibodies against ribosomal fractions of other strains of N. gonorrhoeae were detected in patient sera, but no ribosomal fraction prepared from nongonococcal organisms reacted with patient sera. Absorption of the sera with nongonococcal organisms did not affect the antibody activity in the sera of asymptomatic patients. The nongonococcal flora may have very little influence on this serological diagnosis, and differences in antigenicity among various strains of N. gonorrhoeae were not observed in ribosomal fractions.
In our preliminary study, antibodies to ribosomal fractions started to increase 2 weeks after the appearance of clinical symptoms in a patient having an acute gonococcal infection. After chemotherapeutic treatment failed, the antibody activities reached a maximum 2 months after infection began and continued for a long time at a significantly high titer. Antibody to the OMC appeared 1 week after the appearance of clinical symptoms, and the duration of antibody response could last as long as 1 month at the high titer either with or without treatment. Sera obtained from asymptomatic patients reacted with the OMC, but the antibody titer was very low. Subcellular antigens, such as ribosomal fractions, might be released from organisms shortly after the organisms are engulfed by leukocytes, and the antigen release could last until the organisms are completely eliminated. This could account for the high levels of antibody activity in the sera of asymptomatic carriers.
Bacterial culturing is not always successful in detecting an asymptomatic carrier because of the variety of sensitivities of culture results. Considering such situations, a serological study with the PRF PHA might be sensitive and specific enough to perform an epidemiological study on asymptomatic carriers. The ELISA with PRF antigen is also effective, and there has been a report that a radioimmunoassay with a labeled pilus antigen could be a useful tool in the serodiagnosis of asymptomatic gonorrhea (23) . However, the PRF PHA is more useful because it is convenient and easy and has a low cost.
Athough this study was performned with a limited number of subjects, its results contain information which suggests that the PRF PHA could be used as a screening test for the diagnosis of asymptomatic gonorrhea. A study is now in progress to determine the influence of acute gonococcal infections on the PRF PHA and to determine whether cross-reacting anti-PRF antibody occurs in patients with other types of infections.
